# Vivos Therapeutics, Inc.: Form SCHEDULE 13D, filed Jun 16, 2025

- Company: [Vivos Therapeutics, Inc.](/companies/vvos.md) (CIK 1716166)
- Form: SCHEDULE 13D
- Filed: 2025-06-16
- Accepted by EDGAR: Jun 16, 2025, 19:57 ET
- Period: not reported
- Accession: 0002049575-25-000002
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1716166/000204957525000002/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1716166/000204957525000002/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1716166/000204957525000002/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jun 16, 2025.
Source: SEC EDGAR, the filing index for accession 0002049575-25-000002. Last ingested by Listed: Oct 29, 2026, 15:56 ET. No prices; not investment advice.